Is there a gender gap in secondary prevention of coronary artery disease in Turkey? [Türkiye’de koroner arter hastalığından ikincil korunmada cinsiyet etkisi var mıdır?]

dc.contributor.authorKoçyiğit D.
dc.contributor.authorTokgözoğlu L.
dc.contributor.authorKayıkçıoğlu M.
dc.contributor.authorAltay S.
dc.contributor.authorAydoğdu S.
dc.contributor.authorBarçın C.
dc.contributor.authorBostan C.
dc.contributor.authorÇakmak H.A.
dc.contributor.authorÇatakoğlu A.B.
dc.contributor.authorEmet S.
dc.contributor.authorErgene O.
dc.contributor.authorKalkan A.K.
dc.contributor.authorKaya B.
dc.contributor.authorKaya C.
dc.contributor.authorKaymaz C.
dc.contributor.authorKoylan N.
dc.contributor.authorKültürsay H.
dc.contributor.authorOğuz A.
dc.contributor.authorÖzpelit E.
dc.contributor.authorÜnlü S.
dc.date.accessioned2019-10-27T08:01:39Z
dc.date.available2019-10-27T08:01:39Z
dc.date.issued2018
dc.departmentEge Üniversitesien_US
dc.description.abstractObjective: It has been reported that women receive fewer preventive recommendations regarding pharmacological treatment, lifestyle modifications, and cardiac rehabilitation compared with men who have a similar risk profile. This study was an investigation of the impact of gender on cardiovascular risk profile and secondary prevention measures for coronary artery disease (CAD) in the Turkish population. Methods: Statistical analyses were based on the European Action on Secondary and Primary Prevention through Intervention to Reduce Events (EUROASPIRE)-IV cross-sectional survey data obtained from 17 centers in Turkey. Male and female patients, aged 18 to 80 years, who were hospitalized for a first or recurrent coronary event (coronary artery bypass graft, percutaneous coronary intervention, acute myocardial infarction, or acute myocardial ischemia) were eligible. Results: A total of 88 (19.7%) females and 358 males (80.3%) were included. At the time of the index event, the females were significantly older (p=0.003) and had received less formal education (p<0.001). Non-smoking status (p<0.001) and higher levels of depression and anxiety (both p<0.001) were more common in the female patients. At the time of the interview, conducted between 6 and 36 months after the index event, central obesity (p<0.001) and obesity (p=0.004) were significantly more common in females. LDL-C, HDL-C or HbA1c levels did not differ significantly between genders. The fasting blood glucose level was significantly higher (p=0.003) and hypertension was more common in females (p=0.001). There was no significant difference in an increase in physical activity or weight loss after the index event between genders, and there was no significant difference between genders regarding continuity of antiplatelet, statin, beta blocker or ACEi/ARB II receptor blocker usage (p>0.05). Conclusion: Achievement of ideal body weight, fasting blood glucose and blood pressure targets was lower in women despite similar reported medication use. This highlights the importance of the implementation of lifestyle measures and adherence to medications in women. © 2018 Turkish Society of Cardiology.en_US
dc.description.sponsorshipIstanbul Üniversitesien_US
dc.description.sponsorshipThe EUROASPIRE-IV Turkey study was unconditionally supported by AstraZeneca BioPharmaceuti-cal Company, Istanbul, Turkey. --en_US
dc.identifier.doi10.5543/tkda.2018.45392en_US
dc.identifier.endpage691en_US
dc.identifier.issn1016-5169
dc.identifier.issue8en_US
dc.identifier.pmid30516526en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage683en_US
dc.identifier.urihttps://doi.org/10.5543/tkda.2018.45392
dc.identifier.urihttps://hdl.handle.net/11454/25039
dc.identifier.volume46en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTurkish Society of Cardiologyen_US
dc.relation.ispartofTurk Kardiyoloji Dernegi Arsivien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCardiovascular risk factorsen_US
dc.subjectCoronary artery diseaseen_US
dc.subjectGenderen_US
dc.subjectSecondary preventionen_US
dc.titleIs there a gender gap in secondary prevention of coronary artery disease in Turkey? [Türkiye’de koroner arter hastalığından ikincil korunmada cinsiyet etkisi var mıdır?]en_US
dc.typeArticleen_US

Dosyalar